Rapport Therapeutics logo

Rapport Therapeutics Share Price Today

(NASDAQ: RAPP)

Rapport Therapeutics share price is $10.47 & ₹911.57 as on 6 Mar 2025, 2.30 'hrs' IST

$10.47

0.48

(4.8%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rapport Therapeutics share price in Dollar and Rupees. Guide to invest in Rapport Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rapport Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Rapport Therapeutics share price movements

  • Today's Low: $9.78
    Today's High: $10.62

    Day's Volatility :7.91%

  • 52 Weeks Low: $6.43
    52 Weeks High: $29.74

    52 Weeks Volatility :78.38%

Rapport Therapeutics (RAPP) Returns

PeriodRapport Therapeutics Inc.Index (Russel 2000)
3 Months
-48.35%
0.0%
6 Months
-50.66%
0.0%
1 Year
-49.66%
0.0%
3 Years
-49.66%
-11.6%

Rapport Therapeutics (RAPP) Key Statistics

in dollars & INR

Previous Close
$9.99
Open
$10.02
Today's High
$10.62
Today's Low
$9.78
Market Capitalization
$762.3M
Today's Volume
$293.8K
52 Week High
$29.74
52 Week Low
$6.43
Revenue TTM
$0.0
EBITDA
$-61.8M
Earnings Per Share (EPS)
$-1.72
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Rapport Therapeutics Stock (RAPP) from India?

It is very easy for Indian residents to invest directly in Rapport Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rapport Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rapport Therapeutics or RAPP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rapport Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rapport Therapeutics shares which would translate to 0.083 fractional shares of Rapport Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rapport Therapeutics, in just a few clicks!

Returns in Rapport Therapeutics (RAPP) for Indian investors in Rupees

The Rapport Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rapport Therapeutics investment value today

Current value as on today

₹55,401

Returns

₹44,599

(-44.6%)

Returns from Rapport Therapeutics Stock

₹49,663 (-49.66%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Rapport Therapeutics (RAPP)

100%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rapport Therapeutics Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Rapport Therapeutics

Analyst Forecast on Rapport Therapeutics Stock (RAPP)

What analysts predicted

Upside of 234.29%

Target:

$35.00

Current:

$10.47

Insights on Rapport Therapeutics Stock (Ticker Symbol: RAPP)

  • Price Movement

    In the last 1 month, RAPP stock has moved down by -37.5%

Rapport Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapport Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Rapport Therapeutics (RAPP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rapport Therapeutics Inc. logo
-41.1%
-50.66%
-49.66%
-49.66%
-49.66%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rapport Therapeutics Inc. logo
NA
NA
NA
-3.46
0.0
0.0
NA
9.21
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rapport Therapeutics Inc. logo
NA
$762.3M
-49.66%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Rapport Therapeutics

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.
Organization
Rapport Therapeutics
Employees
0
CEO
Mr. Abraham N. Ceesay M.B.A.
Industry
Miscellaneous

Management People of Rapport Therapeutics

NameTitle
Dr. Steven M. Paul M.D.
Founder & Independent Chairman
Mr. Abraham N. Ceesay M.B.A.
CEO, President, Treasurer & Director
Dr. Troy A. Ignelzi
Chief Financial Officer
Ms. Cheryl Gault
Chief Operating Officer
Mr. David Bredt M.D., Ph.D.
Founder & Chief Scientific Officer
Ms. Karina Chmielewski
Chief Information Officer & Head of Operations
Ms. Julie DiCarlo
Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson
Chief People Officer
Mr. Swamy Yeleswaram Ph.D.
Chief Development Officer
Dr. Arnold R. Gammaitoni Pharm.D.
Senior Vice President of Medical Affairs

Important FAQs about investing in RAPP Stock from India :

What is Rapport Therapeutics share price today?

Rapport Therapeutics share price today stands at $10.47, Open: $10.02 ; Previous Close: $9.99 ; High: $10.62 ; Low: $9.78 ; 52 Week High: $29.74 ; 52 Week Low: $6.43.

The stock opens at $10.02, after a previous close of $9.99. The stock reached a daily high of $10.62 and a low of $9.78, with a 52-week high of $29.74 and a 52-week low of $6.43.

Can Indians buy Rapport Therapeutics shares?

Yes, Indians can invest in the Rapport Therapeutics (RAPP) from India.

With INDmoney, you can buy Rapport Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rapport Therapeutics at zero transaction cost.

How can I buy Rapport Therapeutics shares from India?

It is very easy to buy Rapport Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rapport Therapeutics (RAPP) be purchased?

Yes, you can buy fractional shares of Rapport Therapeutics with INDmoney app.

What are the documents required to start investing in Rapport Therapeutics stocks?

To start investing in Rapport Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rapport Therapeutics Stock (RAPP)?

Today’s highest price of Rapport Therapeutics (RAPP) is $10.62.

Today’s lowest price of Rapport Therapeutics (RAPP) is $9.78.

What is today's market capitalisation of Rapport Therapeutics?

Today's market capitalisation of Rapport Therapeutics RAPP is 762.3M

What is the 52 Week High and Low Range of Rapport Therapeutics Stock (RAPP)?

  • 52 Week High

    $29.74

  • 52 Week Low

    $6.43

What are the historical returns of Rapport Therapeutics (RAPP)?

  • 1 Month Returns

    -41.1%

  • 3 Months Returns

    -50.66%

  • 1 Year Returns

    -49.66%

  • 5 Years Returns

    -49.66%

Who is the Chief Executive Officer (CEO) of Rapport Therapeutics ?

Mr. Abraham N. Ceesay M.B.A. is the current Chief Executive Officer (CEO) of Rapport Therapeutics.